Our Services
Medical Information
Helpful Resources
Published on: 3/18/2026
Auvelity (dextromethorphan-bupropion): Fast-Acting Depression Treatment Overview
Auvelity is an FDA-approved oral medication combining dextromethorphan and bupropion to treat major depressive disorder (MDD) in adults. Unlike SSRIs and SNRIs that primarily target serotonin, Auvelity works on NMDA glutamate receptors along with dopamine and norepinephrine pathways. Clinical trials show some adults experience significant symptom relief within about 1 week, with greater overall improvement versus placebo—though individual response times vary.
Key considerations include common side effects (dizziness, insomnia, headache), elevated blood pressure, seizure risk, boxed warnings for suicidality in young adults, drug interactions, cost, and the need for close clinician monitoring. Auvelity is not appropriate for everyone, including people with seizure disorders or certain medication combinations.
If you're struggling with persistent low mood, fatigue, or loss of interest, understanding what's driving your symptoms is the critical first step before discussing treatments like Auvelity with a clinician. A free, instant, online symptom check from Ubie Health uses AI built with physicians to help you identify possible causes, prepare smarter questions for your doctor, and navigate next steps with clarity. It takes only a few minutes and could meaningfully shape the care you receive.
Reviewed for medical accuracy: 06/23/2026
If you've tried one or more antidepressants and still feel stuck, you're not alone. Many people with major depressive disorder (MDD) do not get full relief from their first medication. That's why Auvelity reviews have been getting attention. This newer prescription medication works differently from traditional antidepressants—and for some people, it may start working faster.
But is it right for you? Let's break down what credible research shows, what real-world Auvelity reviews are saying, and what you should consider before making any changes.
Auvelity is an FDA-approved medication for major depressive disorder (MDD) in adults. It combines two medicines:
This combination works differently from common antidepressants like SSRIs (such as sertraline or fluoxetine), which mainly target serotonin.
Instead of focusing only on serotonin, Auvelity acts on:
This matters because depression is more complex than just "low serotonin." For some people, targeting multiple brain systems may lead to better results.
There are two main reasons:
In clinical trials, some patients reported improvement in depressive symptoms in as little as 1 week. That's significant because traditional antidepressants often take 4–6 weeks to show full effects.
In controlled studies:
That "1-week step" is one reason many Auvelity reviews describe it as a turning point after months or years of frustration.
However, not everyone responds in a week. Some people still require several weeks to feel meaningful change.
Up to 30–50% of people with depression do not respond fully to their first antidepressant. When SSRIs and SNRIs fail, doctors may try:
Auvelity offers another option because it works on glutamate pathways, similar in concept (but not identical) to ketamine-based treatments.
Some patients in published trials had previously used other antidepressants without full relief. In that group, Auvelity still showed measurable improvement.
That's why many online Auvelity reviews come from people who say things like:
Still, results vary. No antidepressant works for everyone.
According to FDA-reviewed clinical trial data:
Common side effects include:
Serious risks can include:
This is why medical screening is essential before starting.
Based on clinical guidance and emerging Auvelity reviews, it may be worth discussing with your doctor if:
It may not be appropriate if you:
A full medication review is critical.
While individual experiences vary, common themes include:
It's important to remember: online Auvelity reviews represent personal stories—not medical conclusions. Some people have dramatic improvements. Others notice only mild changes. A smaller group may discontinue due to side effects.
The idea of a 1-week shift is exciting. But here's the balanced truth:
Medication is one tool—not the entire solution.
Before discussing treatment options like Auvelity with your doctor, it can be helpful to understand the full scope of your symptoms. Ubie's free AI-powered Depression Symptom Checker takes just a few minutes to complete and provides personalized insights you can bring to your next appointment to have a more informed conversation about what treatments might work best for you.
Depression itself can be serious and, in some cases, life-threatening. If you experience:
You should seek immediate medical attention.
Antidepressants, including Auvelity, carry a boxed warning about increased suicidal thoughts in some younger patients, particularly early in treatment. Close monitoring during the first few weeks is essential.
Always speak to a doctor before:
Abrupt changes can be dangerous.
Not necessarily "better"—but different.
SSRIs:
Auvelity:
For some people, SSRIs work extremely well and are well tolerated. For others, they don't provide enough relief. That's where alternatives like Auvelity may fit in.
Treatment decisions should be individualized.
Because Auvelity is newer, insurance coverage varies. Some patients report higher out-of-pocket costs compared to generic antidepressants.
Before starting:
Financial stress can worsen depression, so planning ahead matters.
Auvelity reviews reflect real experiences—but they're not medical advice.
The credible clinical data shows:
If you feel like your current medication isn't working, that doesn't mean you're out of options. It means it's time for a new conversation.
Depression is treatable. But it often requires:
If your symptoms feel persistent, worsening, or overwhelming, speak to a doctor promptly. Depression is serious—but it is also highly treatable with the right support.
You don't have to figure this out alone.
(References)
* Auvelity (Dextromethorphan/Bupropion) for Major Depressive Disorder. Drugs. 2022 Sep;82(13):1413-1422. doi: 10.1007/s40265-022-01777-6. PMID: 36040713.
* The Efficacy and Safety of AXS-05 in Patients with Major Depressive Disorder: The GEMINI Randomized Clinical Trial. J Clin Psychiatry. 2021 Jul 27;82(4):20m13753. doi: 10.4088/JCP.20m13753. PMID: 34320078.
* Rapid Antidepressant Effects of AXS-05 (Dextromethorphan-Bupropion) in Patients with Major Depressive Disorder: The ASCEND Study. J Clin Psychiatry. 2020 Sep 22;81(5):20m13348. doi: 10.4088/JCP.20m13348. PMID: 32970732.
* Efficacy and safety of AXS-05 in patients with major depressive disorder and an inadequate response to prior antidepressant treatment: The STRIDE-1 study. J Affect Disord. 2023 Feb 1;322:201-209. doi: 10.1016/j.jad.2022.10.093. Epub 2022 Nov 2. PMID: 36328014.
* Dextromethorphan/Bupropion for Major Depressive Disorder: A Review of Efficacy and Safety. CNS Drugs. 2023 Feb;37(2):123-132. doi: 10.1007/s40263-022-00971-1. PMID: 36585642.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.